中国卫生标准管理
中國衛生標準管理
중국위생표준관리
China Health Standard Management
2015年
27期
91-92
,共2页
急性脑梗死%尤瑞克林%依达拉奉%血清C反应蛋白%神经功能
急性腦梗死%尤瑞剋林%依達拉奉%血清C反應蛋白%神經功能
급성뇌경사%우서극림%의체랍봉%혈청C반응단백%신경공능
Acute cerebral infarction%Urinary kalidinogenase%Edaravone%Serum C reactive protein%Nerve function
目的 探究尤瑞克林联合依达拉奉对急性脑梗死患者血清C反应蛋白和神经功能的影响.方法 选取54例急性脑梗死患者,数字表法分为对照组和观察组,每组27例,分别采用依达拉奉和依达拉奉+尤瑞克林治疗.结果 观察组患者治疗总有效率、NIHSS(神经功能缺损)评分以及血清C反应蛋白等均优于对照组(P<0.05).结论 急性脑梗死采用尤瑞克林联合依达拉奉治疗,临床疗效良好.
目的 探究尤瑞剋林聯閤依達拉奉對急性腦梗死患者血清C反應蛋白和神經功能的影響.方法 選取54例急性腦梗死患者,數字錶法分為對照組和觀察組,每組27例,分彆採用依達拉奉和依達拉奉+尤瑞剋林治療.結果 觀察組患者治療總有效率、NIHSS(神經功能缺損)評分以及血清C反應蛋白等均優于對照組(P<0.05).結論 急性腦梗死採用尤瑞剋林聯閤依達拉奉治療,臨床療效良好.
목적 탐구우서극림연합의체랍봉대급성뇌경사환자혈청C반응단백화신경공능적영향.방법 선취54례급성뇌경사환자,수자표법분위대조조화관찰조,매조27례,분별채용의체랍봉화의체랍봉+우서극림치료.결과 관찰조환자치료총유효솔、NIHSS(신경공능결손)평분이급혈청C반응단백등균우우대조조(P<0.05).결론 급성뇌경사채용우서극림연합의체랍봉치료,림상료효량호.
Objective To explore the impact of urinary kalidinogenase combined with edaravone on serum C reactive protein and nerve function in patients with acute cerebral infarction.Methods 54 patients with acute cerebral infarction were selected. According to digital table method.they were divided into the control group and the observation group,27 cases in each group. Respectively,using edaravone and edaravone+Urinary kalidinogenase for treatment.Results In the observation group,the total effective rate, NIHSS(neurological function defect)score and serum C reactive protein were better than those of the control group(P<0.05).Conclusion Urinary kalidinogenase combined with edaravone in treatment of patients with acute cerebral infarction,the clinical curative effect is remarkable.
